New study follows lupus patients from day one to unlock better treatments
NCT ID NCT07209540
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study follows 700 adults recently diagnosed with lupus across Europe for up to 5 years. Researchers will track symptoms, treatment, and quality of life, and collect blood and urine samples. The goal is to understand how lupus develops early on and find markers that predict which treatments work best, paving the way for personalized care.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SYSTEMIC LUPUS ERYTHEMATOSUS (SLE) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a Three-Drug combo quiet lupus kidney flares?
- Can a new antibody tame lupus flares?
- Can a single infusion of reprogrammed immune cells quiet lupus kidney disease?
- Eye tests could spot silent vision damage in lupus patients
- Could a simple blood test predict lupus in children with ITP?
- Can an extra shot boost COVID protection in autoimmune patients?